MedTrace Logo

The CUSA Clarity Soft Tissue Removal Study

NCT04298268 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-02-08

No results posted yet for this study

Summary

To investigate the clinical performance and surgeon preferences of the CUSA® Clarity Ultrasonic Surgical Aspirator System for soft tissue removal during surgical procedures. This will be evaluated through the effectiveness of soft tissue removal per surgeon assessment and Incidence of Adverse Device Effects.

Conditions

  • Benign, Malignant Tumors or Other Soft Tissue Removal
  • Nephrectomy or Partial Nephrectomy With Parenchyma Removal

Interventions

DEVICE

CUSA Clarity Ultrasonic Surgical Aspirator System use

Assessment of the CUSA® Clarity Ultrasonic Surgical Aspirator System use during urological or general surgery for soft tissue removal

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Jason Marzuola · Integra LifeSciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-30
Primary Completion
2021-11-24
Completion
2021-11-24
FDA Device
Yes

Countries

  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04298268 on ClinicalTrials.gov